4.7 Article

Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease

期刊

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.04.050

关键词

coronary heart disease; remnant lipoproteins; risk; stroke; triglyceride-rich lipoproteins

资金

  1. National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]
  2. National Institutes of Health through the American Recovery and Reinvestment Act [5RC2HL102419]
  3. Denka Seiken

向作者/读者索取更多资源

BACKGROUND Hypertriglyceridemia is associated with increased remnant-like particle cholesterol (RLP-C) and triglycerides in low-density lipoprotein (LDL-TG). Recent studies have focused on atherogenicity of RLP-C, with few data on LDL-TG. OBJECTIVES The aim of this study was to examine associations of RLP-C and LDL-TG with incident cardiovascular disease (CVD) events and genetic variants in the ARIC (Atherosclerosis Risk In Communities) study. METHODS Fasting plasma RLP-C and LDL-TG levels were measured in 9,334 men and women without prevalent CVD. Participants were followed for incident CVD events (coronary heart disease and ischemic stroke) for up to 16 years. Associations between LDL-TG and RLP-C levels and genetic variants were assessed by whole-exome sequencing using single-variant analysis for common variants and gene-based burden tests for rare variants; both an unbiased and a candidate gene approach were explored. RESULTS RLP-C and LDL-TG levels were correlated with triglyceride levels (r = 0.85 and r = 0.64, p < 0.0001). In minimally adjusted analyses, RLP-C and LDL-TG were associated with CVD risk, but in models adjusted for traditional risk factors including lipids, only LDL-TG was associated with incident CHD (hazard ratio: 1.28; 95% confidence interval: 1.10 to 1.50) and stroke (hazard ratio: 1.47; 95% confidence interval: 1.13 to 1.92). A common APOE variant, rs7412, had the strongest association with LDL-TG and RLP-C (p < 5 x 10(-8)). CONCLUSIONS RLP-C and LDL-TG levels were predictive of CVD and associated with APOE variants. LDL-TG may represent a marker of dysfunctional remnant lipoprotein metabolism associated with increased CVD risk. Further research is needed to determine whether LDL-TG plays a causal role in CVD and may be a target for therapy. (J Am Coll Cardiol 2018; 72: 156-69) (C) 2018 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Peripheral Vascular Disease

Renin: Measurements, Correlates, and Associations With Long-Term Adverse Kidney Outcomes

Matthew F. Blum, Jingsha Chen, Aditya Surapaneni, Stephen T. Turner, Christie M. Ballantyne, Paul A. Welling, Anna Koettgen, Josef Coresh, Deidra C. Crews, Morgan E. Grams

Summary: This study investigated the association of renin with adverse kidney outcomes and compared different measurement strategies. The results showed that renin levels measured by SomaScan modified nucleotide aptamer assay were predictive of chronic kidney disease, end-stage kidney disease, and mortality. The SomaScan measurement was moderately correlated with plasma renin activity and highly correlated with renin level from Olink.

AMERICAN JOURNAL OF HYPERTENSION (2023)

Article Urology & Nephrology

Testican-2 Is Associated with Reduced Risk of Incident ESKD

Donghai Wen, Linda Zhou, Zihe Zheng, Aditya Surapaneni, Christie M. Ballantyne, Ron C. Hoogeveen, Michael G. Shlipak, Sushrut S. Waikar, Ramachandran S. Vasan, Paul L. Kimmel, Ruth F. Dubin, Rajat Deo, Harold I. Feldman, Peter Ganz, Josef Coresh, Morgan E. Grams, Eugene P. Rhee

Summary: Testican-2, a protein released into circulation by the kidneys, is positively correlated with eGFR and eGFR slope. However, it is unknown whether higher testican-2 levels are associated with lower risk of ESKD.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Review Medical Laboratory Technology

Clonal hematopoiesis of indeterminate potential and cardiovascular disease

Seyedmohammad Saadatagah, Christie M. Ballantyne

Summary: Age is a crucial risk factor for cardiovascular disease, as genetic mutations occur with aging, leading to somatic mosaicism. Clonal hematopoiesis resulting from somatic mutations, known as CHIP, has been associated with an increased risk of cardiovascular disease. Recent advances in exome-sequencing projects have enabled the study of CHIP frequency, gene-specific analyses, and potential therapeutic implications for preventing cardiovascular disease.

TRANSLATIONAL RESEARCH (2023)

Article Pharmacology & Pharmacy

Severe hypercholesterolemia in a patient with very low albumin and normal renal function

Mini G. Varughese, Matthew R. Deshotels, Lilei Zhang, Christie M. Ballantyne

Summary: A 20-year-old male presented with severe elevation in low-density lipoprotein cholesterol (LDL-C) and was initially tested negative for familial hypercholesterolemia. Further genetic testing revealed homozygous variants in the ALB gene, indicating congenital analbuminemia (CAA) as the cause of severe hyperlipidemia. CAA is a rare autosomal recessive disorder with a frequency of about 1:1,000,000. Pathological variants in the ALB gene disrupt albumin synthesis and can lead to gross hyperlipidemia and hypercholesterolemia. Early diagnosis through genetic examination is crucial for initiating lipid-lowering treatments and preventing premature coronary artery disease.

JOURNAL OF CLINICAL LIPIDOLOGY (2023)

Article Biochemical Research Methods

A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study

Bruno Bohn, Pamela L. Lutsey, Weihong Tang, James S. Pankow, Faye L. Norby, Bing Yu, Christie M. Ballantyne, Eric A. Whitsel, Kunihiro Matsushita, Ryan T. Demmer

Summary: This study compared the proteome of statin users and nonusers and found differences in proteins unrelated to lipid metabolism. Further investigation into these differences may help elucidate the pleiotropic effects of statins.

JOURNAL OF PROTEOMICS (2023)

Letter Cardiac & Cardiovascular Systems

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease

Salim S. S. Virani, David J. J. Ramsey, Dax Westerman, Mark K. K. Kuebeler, Liang Chen, Julia M. M. Akeroyd, Glenn T. T. Gobbel, Christie M. M. Ballantyne, Laura A. A. Petersen, Alexander Turchin, Michael E. E. Matheny

CIRCULATION (2023)

Letter Cardiac & Cardiovascular Systems

Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease

Yiyi Zhang, Jacqueline S. Dron, Brandon K. Bellows, Amit V. Khera, Junxiu Liu, Pallavi P. Balte, Elizabeth C. Oelsner, Sami Samir Amr, Matthew S. Lebo, Anna Nagy, Gina M. Peloso, Pradeep Natarajan, Jerome I. Rotter, Cristen Willer, Eric Boerwinkle, Christie M. Ballantyne, Pamela L. Lutsey, Myriam Fornage, Donald M. Lloyd-Jones, Lifang Hou, Bruce M. Psaty, Joshua C. Bis, James S. Floyd, Ramachandran S. Vasan, Nancy L. Heard-Costa, April P. Carson, Michael E. Hall, Stephen S. Rich, Xiuqing Guo, Dhruv S. Kazi, Sarah D. de Ferranti, Andrew E. Moran

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

Nicolas Girerd, Daniel Levy, Kevin Duarte, Joao Pedro Ferreira, Christie Ballantyne, Timothy Collier, Anne Pizard, Jens Bjoerkman, Javed Butler, Andrew Clark, John G. Cleland, Christian Delles, Javier Diez, Arantxa Gonzalez, Mark Hazebroek, Jennifer Ho, Anne-Cecile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A. Staessen, Job Verdonschot, Stephane Heymans, Patrick Rossignol, Faiez Zannad

Summary: This study identified protein biomarkers associated with new-onset heart failure in three independent cohorts. The inclusion of these biomarkers in addition to clinical risk factors improved the prediction of heart failure risk. The B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide were found to be particularly relevant in predicting heart failure.

CIRCULATION-HEART FAILURE (2023)

Article Endocrinology & Metabolism

Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study

Suzanne V. Arnold, James A. de Lemos, Luke Zheng, Robert S. Rosenson, Christie M. Ballantyne, Shushama Alam, Deepak L. Bhatt, Christopher P. Cannon, Mikhail Kosiborod, GOULD Investigators

Summary: The study aimed to examine the improvement in the use of optimal medical therapy (OMT) for patients with atherosclerotic cardiovascular disease (ASCVD) and diabetes. The study found that the use of secondary prevention in US patients with ASCVD and diabetes was suboptimal, with minimal improvement over time.

DIABETES OBESITY & METABOLISM (2023)

Article Cardiac & Cardiovascular Systems

Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study

Xiaoming Jia, Leo Buckley, Caroline Sun, Mahmoud Al Rifai, Bing Yu, Vijay Nambi, Salim S. Virani, Elizabeth Selvin, Kunihiro Matsushita, Ron C. Hoogeveen, Josef Coresh, Amil M. Shah, Christie M. Ballantyne

Summary: Higher levels of interleukin-6 and interleukin-18 in older adults are associated with an increased risk of global cardiovascular disease (including coronary heart disease, stroke, and heart failure) and death. The association between interleukin-6 and global cardiovascular disease is stronger than that for interleukin-18, and remains significant even after adjustments for other biomarkers.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study

Lena Mathews, Xiao Hu, Ning Ding, Junichi Ishigami, Mahmoud Al Rifai, Ron C. C. Hoogeveen, Josef Coresh, Christie M. M. Ballantyne, Elizabeth Selvin, Kunihiro Matsushita

Summary: A study on 9205 participants from the ARIC study found that higher levels of GDF15 protein were associated with bleeding events and improved the prediction of bleeding risk in individuals without cardiovascular disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry

Marina Cuchel, Paul C. Lee, Lisa C. Hudgins, P. Barton Duell, Zahid Ahmad, Seth J. Baum, MacRae F. Linton, Sarah D. de Ferranti, Christie M. Ballantyne, John A. Larry, Linda C. Hemphill, Iris Kindt, Samuel S. Gidding, Seth S. Martin, Patrick M. Moriarty, Paul P. Thompson, James A. Underberg, John R. Guyton, Rolf L. Andersen, David J. Whellan, Irwin Benuck, John P. Kane, Kelly Myers, William Howard, David Staszak, Allison Jamison, Mary C. Card, Mafalda Bourbon, Joana R. Chora, Daniel J. Rader, Joshua W. Knowles, Katherine Wilemon, Mary P. McGowan

Summary: This study investigated the diagnosis and treatment of HoFH in the United States and found a low diagnosis rate and low treatment rate, highlighting the need for enhanced screening and treatment to reduce the burden of the disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT

Brian Olshansky, Deepak L. L. Bhatt, Michael Miller, Ph. Gabriel Steg, Eliot A. A. Brinton, Terry A. A. Jacobson, Steven B. B. Ketchum, Ralph T. T. Doyle Jr, Rebecca A. A. Juliano, Lixia Jiao, Peter R. R. Kowey, James A. A. Reiffel, Jean-Claude Tardif, Christie M. M. Ballantyne, Mina K. K. Chung

Summary: In the REDUCE-IT study, icosapent ethyl (IPE) reduced cardiovascular events but was associated with increased atrial fibrillation/atrial flutter (AF) hospitalization. The study analyzed the relationships between IPE and outcomes in patients with or without prior AF and with or without in-study AF hospitalization. Overall, in-study AF hospitalization rates were higher in patients with prior AF, especially in those randomized to IPE. Serious bleeding rates also trended higher in these patients. However, patients with prior AF or in-study AF hospitalization showed consistent risk reductions in cardiovascular events with IPE.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Biochemistry & Molecular Biology

Oxidative Stress and Cardiovascular Risk Factors: The Coronary Artery Risk Development in Young Adults (CARDIA) Study

Amir S. Heravi, Di Zhao, Erin D. Michos, Henrique Doria De Vasconcellos, Bharath Ambale-Venkatesh, Donald Lloyd-Jones, Pamela J. Schreiner, Jared P. Reis, James M. Shikany, Cora E. Lewis, Chiadi E. Ndumele, Eliseo Guallar, Pamela Ouyang, Ron C. Hoogeveen, Joao A. C. Lima, Wendy S. Post, Dhananjay Vaidya

Summary: This study investigated the association between oxidative stress and cardiovascular diseases, finding that female individuals had higher levels of oxidative stress. Furthermore, factors such as higher body mass index, lipid levels, smoking, and lack of physical activity were also associated with higher oxidative stress. This suggests that oxidative stress may play an important role in cardiovascular diseases.

ANTIOXIDANTS (2023)

暂无数据